EMPLOYMENT AGREEMENTEmployment Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis AGREEMENT (the “Agreement”) is made and effective as of the 23rd day of September, 2021 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Company”) and LAURIE A. MYERS, whose address is [**] (the “Executive”). (The Company and the Employee hereinafter sometimes referred to as the “Parties”.)
INCENTIVE STOCK OPTION GRANT AGREEMENT CINGULATE INC.Incentive Stock Option Grant Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Cingulate Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Cingulate Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
RESTRICTED STOCK UNIT AWARD AGREEMENT CINGULATE INC.Restricted Stock Unit Award Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis Restricted Stock Unit Award Agreement (the “Agreement” or “Award Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A, is entered into between Cingulate Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).
RESTRICTED STOCK AWARD AGREEMENT CINGULATE INC.Restricted Stock Award Agreement • September 27th, 2021 • Cingulate Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis Restricted Stock Award Agreement (the “Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A (the “Award Date”), is entered into between Cingulate Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).